Cellebrite Completes Public Warrant Redemption
Ticker: CLBT · Form: 6-K · Filed: Sep 18, 2024 · CIK: 1854587
| Field | Detail |
|---|---|
| Company | Cellebrite Di Ltd. (CLBT) |
| Form Type | 6-K |
| Filed Date | Sep 18, 2024 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.10, $11.50, $11,622.40 |
| Sentiment | neutral |
Sentiment: neutral
Topics: warrants, redemption, capital-structure
TL;DR
Cellebrite is calling back all its public warrants on Sept 18, 2024.
AI Summary
On September 18, 2024, Cellebrite DI Ltd. announced the results of its previously disclosed redemption of all outstanding public warrants. The company is redeeming these warrants, which were issued to purchase ordinary shares, as part of its financial operations.
Why It Matters
This action by Cellebrite DI Ltd. indicates a move to simplify its capital structure by eliminating outstanding warrants, potentially impacting its share count and financial obligations.
Risk Assessment
Risk Level: low — The filing is a routine report of a completed action (warrant redemption) and does not introduce new financial risks.
Key Players & Entities
- Cellebrite DI Ltd. (company) — Registrant
- September 18, 2024 (date) — Date of press release and redemption announcement
FAQ
What type of securities are being redeemed by Cellebrite DI Ltd.?
Cellebrite DI Ltd. is redeeming all of its outstanding public warrants to purchase ordinary shares.
When was the redemption of public warrants announced?
The results of the redemption were announced on September 18, 2024.
What is the par value of Cellebrite's ordinary shares?
The par value of Cellebrite's ordinary shares is NIS 0.00001 per share.
Under which form does Cellebrite DI Ltd. file its annual reports?
Cellebrite DI Ltd. files its annual reports under cover of Form 20-F.
What is the principal executive office address for Cellebrite DI Ltd.?
The principal executive office is located at 94 Shlomo Shmelzer Road, Petah Tikva 4970602, Israel.
Filing Stats: 778 words · 3 min read · ~3 pages · Grade level 13.4 · Accepted 2024-09-18 16:28:28
Key Financial Figures
- $0.10 — in each case for a redemption price of $0.10 per Warrant. The Public Warrants were
- $11.50 — rcised for cash at an exercise price of $11.50 per Ordinary Share in exchange for an a
- $11,622.40 — ts for an aggregate redemption price of $11,622.40. Following the Redemption Date, the Com
Filing Documents
- ea0214950-6k_cellebrite.htm (6-K) — 17KB
- ea021495001ex99-1_cellebrite.htm (EX-99.1) — 11KB
- 0001213900-24-079906.txt ( ) — 29KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Cellebrite DI Ltd. September 18, 2024 By: /s/ Dana Gerner Dana Gerner Chief Financial Officer 2